Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salmenpera, M
Right arrow Articles by Heikkila, J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Salmenpera, M
Right arrow Articles by Heikkila, J

Chest, Vol 83, 739-743, Copyright © 1983 by American College of Chest Physicians


ARTICLES

Hemodynamic responses to beta-adrenergic blockade with metoprolol and pindolol after coronary artery bypass surgery

M Salmenpera, H Yrjola and J Heikkila

Varying ancillary properties of beta-adrenergic blocking drugs, such as intrinsic sympathomimetic activity or beta 1-selectivity, are known to evoke different hemodynamic effects. These differences may be relevant during hemodynamically unstable conditions. Twenty patients undergoing elective coronary artery bypass surgery were matched in two groups and given either metoprolol tartrate (0.03 mg/kg) or pindolol (0.003 mg/kg) intravenously during recovery from surgery. Heart rate (p less than 0.01) and the rate-pressure product (p less than 0.05) were equally reduced by both beta-blocking drugs. Pindolol also caused a minor decrease in cardiac output (p less than 0.05) and a respective increase in the systemic vascular resistance; all other variables remained stable. It is plausible that in the presence of significant adrenalinemia, which constantly develops after coronary artery surgery, the nonselective pindolol blocks both beta 1-receptors and vascular dilatory beta 2-receptors and thereby increases systemic vascular resistance despite its intrinsic sympathetic activity. Thus, if the use of a beta-blocking agent is considered during the immediate recovery stage following coronary artery bypass surgery, a beta 1-selective drug is more desirable than one with an intrinsic sympathomimetic property.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American College of Chest Physicians.